Bromocriptine Reduction of Prolactinoma Size-Reference-Cited by-同舟云学术

Bromocriptine Reduction of Prolactinoma Size

Published:1981-12 Issue:6 Volume:36 Page:716-719
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Corenblum Bernard,Hanley David A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference14 articles.

1. Possible anti-tumor effect of 2-bromo-ergocryptine in two patients with large prolactin-secreting pituitary adenomas (Abstr);Corenblum;Clin Res,1975

2. Rapid regression of pituitary prolactinomas during bromocriptine treatment;Thorner;J Clin Endocrinol Metab,1980

3. Human mixed somatotrophic and lactotrophic pituitary adenomas;Corenblum;J Clin Endocrinol Metab,1976

4. Role of dynamic pituitary testing in patients with hyperprolactinemia;Corenblum;Diag Gynecol Obstet,1979

5. Effects of bromocriptine on pituitary tumor size;McGregor;Br Med J,1979

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Bromocriptine in the Treatment of Gynaecologic Disorders;Asia-Oceania Journal of Obstetrics and Gynaecology;2010-05-24

2. Long-acting injectable bromocriptine (Parlodel LAR**Parlodel LAR, Sandoz, Basel, Switzerland.) in the chronic treatment of prolactin-secreting macroadenomas††Supported by Sandoz, Basel, Switzerland.‡‡Presented at the 12th Panamerican Congress of Endocrinology, Recife, Brazil, November 3 to 9, 1990.;Fertility and Sterility;1993-05

3. Long-acting oral bromocriptine (Parlodel SRO)**Parlodel SRO, Sandoz, Basel, Switzerland. in the treatment of hyperprolactinemia††Supported in part by Sandoz, Basel, Switzerland.;Fertility and Sterility;1992-02

4. Effect of dopamine agonist medication on prolactin producing pituitary adenomas;Virchows Archiv A Pathological Anatomy and Histopathology;1991-09

5. Traitement des adénomes à prolactine;La Revue de Médecine Interne;1990-03